References | Year of publication | Country | Design | Mean follow-up (month) | Basic data | Treatment | QAS | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Group A | Group B | Group A | Group B | ||||||||||
Sample size | Age in years (mean±SD) | Male (%) | Sample size | Age in years (mean±SD) | Male (%) | ||||||||
Hong Liu et al. [20] | 2017 | China | RCT | 36 | 98 | 40.7±4.2 | 51(52%) | 98 | 40.1±4.7 | 50(51%) | 2SHRZ/2–4HRZ | 2SHRZ/7–16HRZ | 3 |
Bo Wang et al. [21] | 2015 | China | RCT | NA | 40 | 42.11±2.09 | 28(70%) | 40 | 42.34±2.21 | 27(68%) | 2SHRZ/2~4HRZ | 2SHRZ/10–16HRZ | 4 |
Yongli He et al. [22] | 2015 | China | RS | 71 | 100 | 41.7±5.4 | 58(%) | 91 | 41.3±5.8 | 50(55%) | 2SHRZ/2–4HRZ | 2SHRZ/7–16HRZ | 7 |
Yirong Zheng et al. [23] | 2014 | China | RS | 78.6 | 38 | NA | NA | 38 | NA | NA | 2SHRZ/2–4HRZ | 2SHRZ/7–16HRZ | 6 |
Upadhyay et al. [19] | 1996 | China | RCT | 175.2 | 25 | 32.6±18.3 | 9(36%) | 89 | NA | 46(52%) | 3SHR/3HR | 3SHR/6HR or 3H+S+ PASNa/15S+ PASNa | 4 |
Zili Wang et al. [14] | 2013 | China | PS | 69.1 | 96 | 37.96 ± 16.3 | 54(56%) | 89 | 41.53 ± 15.76 | 50(56%) | 2SHRZ/2–4HRZ | 2SHRZ/7HRZ | 8 |